Authors: Ashrith G, Elayda MA, Wilson JM
Cardiovascular disease is the leading cause of death in patients who have chronic kidney disease or end-stage renal disease and are undergoing hemodialysis. Chronic kidney disease is a recognized risk factor for premature atherosclerosis. Unfortunately, most major randomized clinical trials that form the basis for evidence-based use of revascularization procedures exclude patients who have renal insufficiency. Retrospective, observational studies suggest that patients with end-stage renal disease and severe coronary occlusive disease have a lower risk of death if they undergo coronary revascularization rather than medical therapy alone. Due to a lack of prospective studies, however, the relative merits of percutaneous versus surgical revasculari…
Further information:
Related posts:
- Innovative HeRO(R) Device Improves Outcomes, Quality Of Life For Kidney Disease Patients
- Study: Kidney disease a big risk for younger, low-income minorities
- Rosuvastatin Beneficial for Patients With Kidney Disease and Elevated CRP
- Check-ups key to curbing kidney disease
- Chronic myeloid leukemia: A disease of youth in Brazil
Posted in